why choose us

Clinical Trials Search

Showing 10,290 of 132,366 result(s)
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Status: Completed

Condition: Squamous Cell Cancer

Interventions: see above

Date: 2023-06-21

INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

Status: Completed

Condition: COVID-19 Pandemic

Interventions: Dose : 1 dose 0.5 ml containing 5 µg inactivated SARS-CoV-2 virus, Tween 80, histidine, Polysorbate 80, Aluminium hydroxide gel, and sodium chloride.

Date: 2023-06-21

Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage

Status: COMPLETED

Condition: Subarachnoid Hemorrhage, Aneurysmal

Interventions: Injection of local anesthetic (e.g.
Bupivacaine) into the pterygopalatine fossa to treat headache related to aneurysmal subarachnoid hemorrhage

Date: 2023-06-21

Behavioral and Pharmacological Reconsolidation Interference in Misophonia

Status: COMPLETED

Condition: Misophonia

Interventions: Single dose of 40 mg propranolol tablet

Date: 2023-06-21

Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors

Status: Completed

Condition: Pancreatic Cancer

Interventions: Subjects will receive VectRx thermal treatment added to 2 cycles of chemotherapy regimen.
The VectRx device will be used under continuous investi

Date: 2023-06-21

Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis

Status: NOT_YET_RECRUITING

Condition: Adolescent Lupus Nephritis

Interventions: Subjects will receive 2 capsules (15.8 mg) BID (twice daily), 3 capsules (23.7 mg) BID or 4 capsules (31.6 mg) BID of voclosporin in addition to stand

Date: 2023-06-21

Behavioral and Pharmacological Reconsolidation Interference in Misophonia

Status: Completed

Condition: Misophonia

Interventions: Single dose of 40 mg propranolol tablet

Date: 2023-06-21

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Status: COMPLETED

Condition: Eye Diseases

Interventions: LNZ101 (Aceclidine;Brimonidine) non-preserved ophthalmic solution

Date: 2023-06-21

Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression

Status: Completed

Condition: Major Depressive Disorder

Interventions: The active neurofeedback session will be done within the 7T MRI.

Date: 2023-06-21

National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring With Data Sharing in Older Adults With Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.

Status: Completed

Condition: Diabetes Mellitus, Type 1

Interventions:

Participants will receive the Share plus intervention:

  • Set up Follow app
  • Start Share plus intervention
  • Communication and

    Date: 2023-06-21